Reply to Yongbao Wei, Ruochen Zhang, and Le Lin's Letter to the Editor re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82:e88
- PMID: 35773149
- DOI: 10.1016/j.eururo.2022.06.008
Reply to Yongbao Wei, Ruochen Zhang, and Le Lin's Letter to the Editor re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82:e88
Comment on
-
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma.Eur Urol. 2022 Feb;81(2):134-137. doi: 10.1016/j.eururo.2021.11.022. Epub 2021 Dec 15. Eur Urol. 2022. PMID: 34920897
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
